Literature DB >> 2713866

Nocturnal gamma-hydroxybutyrate. Effect on periodic leg movements and sleep organization of narcoleptic patients.

M A Bédard1, J Montplaisir, R Godbout, O Lapierre.   

Abstract

Periodic leg movements during sleep (PMS) is a disorder frequently encountered in narcolepsy. In the present study, 12 narcoleptic patients (six with PMS and six without) were recorded in a sleep laboratory for 2 consecutive nights before and after treatment with gamma-hydroxybutyrate (GHB) taken at bedtime for 1 month. Treatment resulted in decreased rapid eye movement (REM) sleep latency and increased REM efficiency without change in the total duration of REM sleep. GHB was associated with the appearance of pathological levels of PMS in patients who were unaffected before treatment. These results are discussed in relation to the role of dopamine in the physiopathology of narcolepsy and PMS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2713866

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  6 in total

Review 1.  Narcolepsy in children: a practical guide to its diagnosis, treatment and follow-up.

Authors:  C Guilleminault; R Pelayo
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Periodic limb movements in sleep exhibit a circadian rhythm that is maximal in the late evening/early night.

Authors:  Jeanne F Duffy; Alex S W Lowe; Edward J Silva; John W Winkelman
Journal:  Sleep Med       Date:  2010-11-18       Impact factor: 3.492

Review 3.  Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations.

Authors:  S Nishino; E Mignot
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

Review 4.  Sodium oxybate: a review of its use in the management of narcolepsy.

Authors:  Dean M Robinson; Gillian M Keating
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 5.  Narcolepsy in the older adult: epidemiology, diagnosis and management.

Authors:  Sangeeta S Chakravorty; David B Rye
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  Brainstem-mediated locomotion and myoclonic jerks. I. Neural substrates.

Authors:  Y Y Lai; J M Siegel
Journal:  Brain Res       Date:  1997-01-16       Impact factor: 3.610

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.